Hadassah

HMO and Hebrew U Students Invent Device to Save Terror Victims

Tuesday, Mar 22 2016

At a time when waves of stabbings are rampant throughout Israel and many victims are experiencing life-threatening chest trauma, the BioDesign: Medical Innovation team of the Hadassah Medical Center and Hebrew University have invented a device that shortens the procedure time of inserting a life-saving chest tube from about 15 minutes to less than 30 seconds.

The reason it is so important to insert a chest tube in the patient very quickly is that chest trauma often leads to potentially fatal pneumothorax, where air accumulates in the space which separates the lungs from the chest wall, causing the lung to collapse and the patient to suffocate. This scenario is believed to be responsible for over a third of preventable deaths following terror attacks and injuries on the battlefield.

Currently, the physician must engage in a two-step procedure. First, the thorax, where the lungs and other vital organs are located, must be decompressed. This is followed by the separating of the tissue to insert a chest tube, which will drain air and blood, allowing the lung to re-inflate. “This is a very laborious and technically difficult procedure," reports Dr. Ariel Drori, an internal medicine expert at Hadassah, "leading caregivers to neglect the second procedure in favor of rapid evacuation to the hospital."

To address this challenge, Dr. Drori partnered with Yoav Kan-Tor and Bettina Nadorp, engineering students at the Hebrew University's Alexander Grass Center for Bioengineering, along with Dr. Liran Levy, a Hadassah pulmonologist, and Chen Goldstein, a Hebrew University business graduate student. Together they developed ThoraXS, a single-step, rapid life-saving solution. Its closed-knife shape allows the physician to penetrate the pleural space (between the lungs and the chest wall) and its mechanical opening mechanism enables the physician to open a portal (point of entry) with one hand and quickly insert a chest tube with the other.

"Our students responded to terror attacks by developing life-saving medical devices, an approach that is the very essence of our BioDesign: Medical Innovation program,” comments Prof. Yaakov Nahmias, Director of the Grass Center. “ThoraXS is a life-saving innovation that exemplifies our commitment to helping the local and global communities through practical research and development projects."

The innovations produced by the Biodesign program participants are commercialized by Yissum, the technology transfer company of the Hebrew University of Jerusalem, and Hadasit, the technology transfer company of the Hadassah Medical Center.

BioDesign: Medical Innovation is a multi-disciplinary, team-based approach to medical innovation, created by Hadassah and Hebrew University. Sponsored by Boston Scientific and the Terumo Medical Corporation, the program brings together outstanding medical fellows and bioengineering and business graduate students, and tutors them in the science and practice of taking a medical innovation to market. The program is chaired by Prof. Chaim Lotan, Director of Hadassah’s Heart Institute, and Prof. Yaakov Nahmias, Director of the Alexander Grass Center for Bioengineering at the Hebrew University.

Comments

From: Barbara on March 22, 2016
Hadassah is always FIRST! Mazel tov and I am so proud!
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Friday, Mar 22 2019

On World TB Day, March 24, Hadassah Celebrates Its Success Treating TB

Hadassah has been working on reducing the incidence of tuberculosis for nearly 100 years.

READ MORE ›
alt_text

Thursday, Mar 21 2019

Large Multinational Study Reveals Benefits of Dapagliflozin for Treatment of Diabetes

With 450 million adults worldwide suffering from diabetes today and an increase to more than 640 million expected by 2040, the need for a safe and effective treatment is ever more compelling.

READ MORE ›
alt_text

Tuesday, Mar 19 2019

Hadassah Genetic Research Demystifies Causes of Day Blindness in Families

Fifteen years ago, Prof. Dror Sharon joined the Hadassah Medical Organization’s Center for Retinal and Macular Degeneration to study the genetics of eye disease.

READ MORE ›
alt_text

Wednesday, Mar 13 2019

Saving Lives, Changing Lives at Hadassah-Neurim Youth Aliyah Village

Henrietta Szold was the mother of Youth Aliyah. The first young Jews who came on their own in the mid-1930s were fleeing Hitler. Many never saw their parents again, and they called her Ima. She met their boats, welcomed them, and became their staunch advocate in the no-frills pre-state Israel.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More